Satellos Bioscience Common Stock Net Tangible Assets

The latest net tangible assets for MSLE is $60M as of June 2026. That compares with $38M in the prior-year period — up 56.0% year over year. Investors often review this figure alongside Satellos Bioscience Common Stock's historical trend and sector peers before judging valuation or financial health.

Over the past year, MSLE's net tangible assets moved from $38M to $60M — a 56.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Satellos Bioscience Common Stock's operating scale or balance-sheet position.

A net tangible assets figure of $60M for MSLE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MSLE's net tangible assets ($60M), review year-over-year change from $38M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.